Production (Stage)
Turnstone Biologics Corp.
TSBX
$0.3329
-$0.0065-1.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.85M | 28.93M | 45.28M | 62.40M | 77.85M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.23M | 3.19M | 3.71M | 3.54M | 4.54M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.79M | 2.10M | 2.15M | 2.46M | 2.59M |
| Total Current Assets | 26.86M | 34.22M | 51.14M | 68.40M | 84.98M |
|
|
|||||
| Total Current Assets | 26.86M | 34.22M | 51.14M | 68.40M | 84.98M |
| Net Property, Plant & Equipment | 488.00K | 5.11M | 6.47M | 7.42M | 8.29M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 267.00K | 811.00K | 873.00K | 1.05M | 1.12M |
| Total Assets | 27.61M | 40.14M | 58.48M | 76.88M | 94.39M |
|
|
|||||
| Total Accounts Payable | 1.70M | 870.00K | 560.00K | 1.49M | 1.42M |
| Total Accrued Expenses | 4.65M | 6.24M | 11.64M | 12.28M | 9.15M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 690.00K | 1.09M | 1.44M | 1.79M | 2.03M |
| Total Finance Division Other Current Liabilities | 227.00K | -- | -- | 78.00K | 47.00K |
| Total Other Current Liabilities | 227.00K | -- | -- | 78.00K | 47.00K |
| Total Current Liabilities | 7.26M | 8.20M | 13.64M | 15.63M | 12.65M |
|
|
|||||
| Total Current Liabilities | 7.26M | 8.20M | 13.64M | 15.63M | 12.65M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 104.00K | 259.00K | 411.00K | 691.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 369.00K | 369.00K | 940.00K | 1.10M | 1.04M |
| Total Liabilities | 7.63M | 8.67M | 14.84M | 17.14M | 14.38M |
|
|
|||||
| Common Stock & APIC | 279.59M | 279.26M | 278.56M | 277.65M | 276.63M |
| Retained Earnings | -259.40M | -247.60M | -234.72M | -217.69M | -196.39M |
| Treasury Stock & Other | -202.00K | -202.00K | -196.00K | -226.00K | -236.00K |
| Total Common Equity | 19.99M | 31.47M | 43.64M | 59.74M | 80.01M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.99M | 31.47M | 43.64M | 59.74M | 80.01M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.99M | 31.47M | 43.64M | 59.74M | 80.01M |
|
|
|||||